相关实验视频
Updated: May 5, 2026

10:34
A High-content Assay for Monitoring AMPA Receptor Trafficking
Published on: January 28, 2019
7.6K
天体细胞转录组分析确定了glypican 5下调作为阿尔茨海默病模型中突触功能障碍的贡献者
bioRxiv : the preprint server for biology
|November 18, 2024
概括
这就是阿尔茨海默病的原因.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 遗传学 是一个遗传学.
背景情况:
- 突触功能障碍是阿尔茨海默病 (AD) 的早期指标,与认知能力下降相关.
- 天星细胞在调节突触形成,成熟,消除和整体功能方面发挥着至关重要的作用.
研究的目的:
- 在阿尔茨海默病中研究突触支持天体细胞功能的改变.
- 在AD小鼠模型中对星形细胞的年龄和性别依赖的转录变化进行表征.
主要方法:
- 利用天体细胞BacTRAP小鼠获得全面的海马天体细胞转录数据.
- 分析了阿尔茨海默氏症病理学的两个不同的小鼠模型:APPswe/PS1dE9和Tau P301S.
- 检查了取决于性别和年龄的转录性改变.
主要成果:
- 两种AD小鼠模型中的星细胞都显示出对突触调节至关重要的基因的下调,包括Glypican 5.
- 这种在小鼠中观察到的转录签名反映了人类死后AD患者样本中的发现.
- 在星球细胞中过度表达Glypican 5,改善了APPswe/PS1dE9小鼠的早期突触功能障碍和改善了空间学习.
结论:
- 天体细胞基因表达的变化,特别是像Glypican 5这样的突触相关因素的下调,与阿尔茨海默病有关.
- 准星状细胞因子是一种潜在的治疗策略,可以缓解阿尔茨海默氏病中的突触功能障碍.
相关概念视频
Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
Alzheimer Disease ll: Pathophysiology
35
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35

